Layer, Chiang, et al. Genome Biology
Foundation Medicine Shows Sequencing-based Cancer Test Can ID Clinically Actionable Mutations
The company, which has targeted the second quarter of 2012 for the commercial launch of its sequencing-based cancer test, demonstrated its performance on 75 cancer tissue samples from non-small cell lung cancer, melanoma, and colon cancer.
New to GenomeWeb? Register here quickly.